ADMA: A critical cardio-renal link in heart failure?

European Journal of Clinical Investigation

Volumn 33, Issue 5, 2003, Pages 361-362

  Zoccali, C ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ARGININE; ASCORBIC ACID; ATRIAL NATRIURETIC FACTOR; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AGING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM LESION; EUROPE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MEDICAL LITERATURE; MORBIDITY; MORTALITY; MULTIPLE REGRESSION; MUSCLE BLOOD FLOW; NEUROENDOCRINE SYSTEM; OXIDATIVE STRESS; PRESSORECEPTOR REFLEX; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SALT LOADING; SHORT SURVEY;

ARGININE; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FAILURE, CHRONIC; NITRIC OXIDE;

EID: 0037907530     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01150.x     Document Type: Short Survey

References (11)

1. Task Force Report. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
2. Piepoli M. Central role of peripheral mechanisms in exercise tolerance in chronic heart failure: the muscle hypothesis. Cardiologia 1998;43:909-17.
3. Drexler H. Nitric oxide synthases in failing human heart. A double edged sword? Circulation 1999;99:2972-5.
4. Welch WJ, Wilcox CS. What is brain nitric oxide synthase doing in the kidney? Curr Opin Nephrol Hypertens 2002;11:109-15.
5. Kielstein JT, Bode-Böger SM, Klein G, Graf S, Haller H, Fliser D. Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure. Eur J Clin. Invest 2003;33:370-5.
6. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-8.
7. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35:681-9.
8. Delles C, Markus P, John S, Gekle M, Schmieder RE. Angiotensin-converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical dimethylarginine in human essential hypertension. Am J Hypertension 2002;15:590-3.
9. Annuk M, Zilmer M, Lind L, Linde T, Fellstrom B. Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 2001;12:2747-52.
10. Sharma R, Davidoff MN. Oxidative stress and endothelial dysfunction in heart failure. Congest Heart Fail 2002;8:165-72.
11. Fujiwara N, Osanai T, Kamada T, Katoh T, Takahashi K, Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Circulation 2000;101:856-61.